Get the Daily Brief
Latest Biotech News
Sanofi Pumps $625M into Venture Fund to Boost Biotech Investments
Sanofi is doubling down on early-stage biotech funding by adding $625 million to its corporate venture fund, Sanofi Ventures. This brings the total capital to $1.4 billion, enabling increased...
AI-Driven Advances Transform Drug Discovery and Clinical Trial Design
Multiple biotech entities reported breakthroughs applying AI to drug discovery and trial optimization. Variational AI announced a $349 million strategic deal with Merck to deploy its Enki...
Groundbreaking CRISPR Technologies Boost Gene Editing Precision and Efficiency
Recent studies highlight enhancements in CRISPR genome editing technologies. Advances include a dual-mode CRISPR system enabling simultaneous gene activation and repression, broadening synthetic...
Advances in Cancer Immunotherapy and Molecular Targeting
Leading research efforts have yielded promising avenues in cancer treatment. Mass General Brigham and Broad Institute demonstrated CRISPR-enhanced CAR-T therapies with improved efficacy against...
AI and Machine Learning Enable Diagnostic and Prognostic Innovations
Artificial intelligence technologies are making substantial inroads into clinical diagnostics. Johns Hopkins researchers devised an AI method to identify neural signatures of schizophrenia and...
Biotech Sector Deals and Strategic Corporate Moves
The biotech industry continues active consolidation and expansion through acquisitions, partnerships, and funding rounds. Celltrion announced a $330 million acquisition of Eli Lilly’s cGMP...
UniQure Gene Therapy Slows Huntington’s Disease Progression
UniQure announced that its experimental gene therapy AMT-130 significantly slowed Huntington’s disease progression by 75% over three years in a Phase 1/2 trial. This pioneering one-time genetic...
Pfizer Accelerates Obesity Pipeline with $4.9B Metsera Acquisition
Pfizer has agreed to acquire Metsera for up to $7.3 billion including milestone payments, re-entering the obesity drug market following prior setbacks. The deal brings Metsera’s portfolio of oral...
Scholar Rock SMA Drug Delayed by FDA Over Manufacturing Issues
The FDA issued a complete response letter to Scholar Rock’s selective anti-latent myostatin antibody apitegromab for spinal muscular atrophy, citing ongoing manufacturing quality concerns at Novo...
AI Advances in Biotech: Lila Sciences and Variational AI Raise Major Funding
Lila Sciences secured $235 million in Series A funding to scale its AI-driven drug discovery platform combining generative AI, robotics, and automation to accelerate scientific experiments and...
Immunotherapy and Oncology: Novel Strategies and Diagnostic Innovations
Recent studies reveal advancements in cancer immunotherapy and diagnostics. Researchers engineered gut bacteria to boost colorectal cancer patient survival, while new antibody-cytokine fusion...
Advances in Genetic and CRISPR Technologies
Pivotal developments include a new dual-mode CRISPR system enabling simultaneous gene activation and repression, expanding synthetic biology applications. Screening approaches have enhanced CRISPR...
Regulatory and Corporate Moves: Sanofi Ventures, Celltrion, and More
Sanofi Ventures announced a $625 million cash infusion to expand investments across biotech and digital health startups, reinforcing its position as a major corporate venture fund amid capital...
Breakthroughs in AI and Diagnostic Tools for Healthcare
The field of healthcare is rapidly adopting artificial intelligence for enhanced diagnostic and operational efficiency. UCLA leads a $16 million initiative to evaluate AI’s role in breast cancer...
New Therapies and Clinical Trial Updates in Rare Diseases
Ionis Pharmaceuticals reported positive pivotal trial results for zilganersen in Alexander disease, an ultra-rare neurological disorder, and plans to file for FDA approval in 2026. Medicure Inc....
Clinical and Biotech Innovations in Patient Care and Device Technology
Innovations extend across diagnostic and therapeutic devices. Heartflow received FDA clearance for its next-generation plaque analysis algorithm demonstrating 21% improved detection over previous...
Pfizer Reenters Obesity Market: $4.9B Acquisition of Metsera
Pfizer has made a decisive move to reestablish itself in the obesity therapeutics market by acquiring Metsera for $4.9 billion upfront, with additional milestones potentially bringing the deal’s...
FDA Approval and Delays Shape Rare and Oncology Drug Landscape
The FDA granted accelerated approval to Stealth BioTherapeutics’ elamipretide for Barth syndrome after a prolonged regulatory journey marked by earlier setbacks. Meanwhile, Bristol Myers announced...
CRISPR and AI Forge New Paths in Precision Medicine and Drug Discovery
Advances in CRISPR technology and AI are driving innovations in therapeutic development and diagnostics. Variational AI entered a collaboration with Merck to apply generative AI for small molecule...
Breakthroughs in Neurological and Psychiatric Disorder Research
Several pioneering studies reported major advances in neurosciences and neurotherapeutics. Ionis Pharmaceuticals succeeded in pivotal trials for an antisense oligonucleotide treating Alexander...